celecoxib and ah 6809

celecoxib has been researched along with ah 6809 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosetti, F; Palumbo, S; Parente, L; Toscano, CD; Weigert, R1
Edwards, RP; Kalinski, P; Muthuswamy, R; Obermajer, N; Odunsi, K1
Bi, Y; Han, M; Jiang, M; Li, S; Xu, J; Xu, X1
Arantes, EC; Faccioli, LH; Hori, JI; Paula-Silva, FW; Serezani, CH; Sorgi, CA; Zamboni, DS; Zoccal, KF1
Deng, L; Feng, D; Liang, H; Liang, J; Ling, B; Yan, K; Zhang, X1

Other Studies

5 other study(ies) available for celecoxib and ah 6809

ArticleYear
The cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination.
    Journal of neurochemistry, 2012, Volume: 121, Issue:3

    Topics: Animals; Apoptosis; Caspase 3; Cattle; Celecoxib; Chelating Agents; Cuprizone; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Demyelinating Diseases; Dinoprostone; Fluorescent Antibody Technique; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin Sheath; Oligodendroglia; Postural Balance; Pyrazoles; Real-Time Polymerase Chain Reaction; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Sulfonamides; Xanthones

2012
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
    Cancer research, 2011, Dec-15, Volume: 71, Issue:24

    Topics: Biphenyl Compounds; CD11b Antigen; Celecoxib; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Monocytes; Myeloid Cells; Ovarian Neoplasms; Prostaglandin Antagonists; Pyrazoles; Receptors, CXCR4; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Tumor Cells, Cultured; Tumor Microenvironment; Xanthones

2011
Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
    Molecular medicine reports, 2015, Volume: 11, Issue:6

    Topics: Animals; Blood Vessels; Breast Neoplasms; Celecoxib; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Endothelial Cells; Female; Inflammation; Lipopolysaccharides; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Receptors, Prostaglandin E; Vascular Endothelial Growth Factor A; Xanthones

2015
Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality.
    Nature communications, 2016, Feb-23, Volume: 7

    Topics: Animals; Arachidonate 5-Lipoxygenase; Blotting, Western; Carrier Proteins; Celecoxib; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dinoprostone; In Vitro Techniques; Indoles; Indomethacin; Inflammasomes; Interleukin-1beta; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Macrophages, Peritoneal; Mice; Mice, Knockout; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphoproteins; Prostaglandin Antagonists; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Reverse Transcriptase Polymerase Chain Reaction; Scorpion Stings; Scorpion Venoms; Scorpions; Xanthones

2016
Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.
    Cell transplantation, 2019, Volume: 28, Issue:1_suppl

    Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Mice, Nude; Neoplasm Grading; Neoplasm Invasiveness; NF-kappa B; Nitriles; Ovarian Neoplasms; Phosphorylation; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Sulfones; Transplantation, Heterologous; Xanthones

2019